Stay updated on Pembrolizumab in Recurrent HNSCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Recurrent HNSCC Clinical Trial page.

Latest updates to the Pembrolizumab in Recurrent HNSCC Clinical Trial page
- CheckyesterdayChange DetectedA new page revision tag (v3.6.3) has replaced the previous v3.6.2 on the study record page, indicating a minor update to the page. The update reflects a version change rather than a change to the study details.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 on the page, indicating a newer version of the study record interface.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe study page gains a recruitment status update ('No longer looking for participants'), which directly affects enrollment. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision note to v3.6.0, while the prior revision note v3.5.5 is removed and the heading 'Intervention/Treatment' is adjusted.SummaryDifference0.4%

- Check30 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing v3.5.4. This indicates a small update to the page's metadata or formatting without altering the study details or data.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a background update to the page's content/structure without changing the study details shown to users.SummaryDifference0.1%

- Check65 days agoChange DetectedThe study record revision was updated to v3.5.3, representing a minor update to the ClinicalTrials.gov entry.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Recurrent HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent HNSCC Clinical Trial page.